Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1497178 | 0.80 | — | — | |
| SCHEMBL19183030 | 0.80 | — | — | |
| SCHEMBL1392903 | 0.71 | — | — | |
| SCHEMBL10534583 | 0.67 | GAA (0.44) | KDM4EALDH1A1MAPT | |
| SCHEMBL13331723 | 0.64 | — | — | |
| SCHEMBL18306655 | 0.64 | — | — | |
| SCHEMBL16168100 | 0.63 | — | — | |
| SCHEMBL10934976 | 0.60 | — | — | |
| SCHEMBL8070209 | 0.59 | PTPRF (0.36) | — | |
| SCHEMBL16076083 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265065-A1 | SELECTIVE PHOSPHATASE INHIBITORS BASED ON ILLUDALIC ACID | THE WEST VIRGINIA UNIVERSITY BOARD OF GOVERNORS ON BEHALF OF WEST VIRGINIA UNIVERSITY | 2023-08-24 | — | — | US | disclosed |
| US-20230265065-A1 | SELECTIVE PHOSPHATASE INHIBITORS BASED ON ILLUDALIC ACID | THE WEST VIRGINIA UNIVERSITY BOARD OF GOVERNORS ON BEHALF OF WEST VIRGINIA UNIVERSITY | 2023-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265065-A1 | SELECTIVE PHOSPHATASE INHIBITORS BASED ON ILLUDALIC ACID | PTPRA, PTPRR, PTPRC | KDM4E 555/4885ALDH1A1 1539/4885MAPT 3505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.